Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
This report contains market size and forecasts of Immuno-Oncology in Italy, including the following market information:
Italy Immuno-Oncology Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in Italy Immuno-Oncology Market 2019 (%)
The global Immuno-Oncology market was valued at 33390 million in 2019 and is projected to reach US$ 56950 million by 2026, at a CAGR of 14.3% during the forecast period. While the Immuno-Oncology market size in Italy was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Immuno-Oncology businesses, with lots of challenges and uncertainty faced by many players of Immuno-Oncology in Italy.
This report also analyses and evaluates the COVID-19 impact on Immuno-Oncology market size in 2020 and the next few years in Italy
Total Market by Segment:
Italy Immuno-Oncology Market, By Type, 2015-2020, 2021-2026 ($ millions)
Italy Immuno-Oncology Market Segment Percentages, By Type, 2019 (%)
- Immune Checkpoint Inhibitors
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Others
Italy Immuno-Oncology Market, By Application, 2015-2020, 2021-2026 ($ millions)
Italy Immuno-Oncology Market Segment Percentages, By Application, 2019 (%)
- Hospitals
- Drugstores
- Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Immuno-Oncology Market Competitors Revenues in Italy, by Players 2015-2020 (Estimated), ($ millions)
Total Immuno-Oncology Market Competitors Revenues Share in Italy, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Bristol-Myers Squibb
- Merck & Co., Inc.
- Roche AG
- AstraZeneca, Plc
- Sanofi S.A.
- Dendreon Pharmaceuticals
- Novartis
- Gilead Sciences Inc.
Immuno-Oncology Market in Italy - Industry Outlook and Forecast 2020-2026
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Immuno-Oncology Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: Italy Immuno-Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Italy Immuno-Oncology Overall Market Size
2.1 Italy Immuno-Oncology Market Size: 2020 VS 2026
2.2 Italy Immuno-Oncology Revenue, Prospects & Forecasts: 2015-2026
3 Company Landscape
3.1 Top Immuno-Oncology Players in Italy (including Foreign and Local Companies)
3.2 Top Italy Immuno-Oncology Companies Ranked by Revenue
3.3 Italy Immuno-Oncology Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Immuno-Oncology Companies in Italy, by Revenue in 2019
3.5 Italy Manufacturers Immuno-Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Oncology Players in Italy
3.6.1 List of Italy Tier 1 Immuno-Oncology Companies
3.6.2 List of Italy Tier 2 and Tier 3 Immuno-Oncology Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Italy Immuno-Oncology Market Size Markets, 2020 & 2026
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Cytokine-Based Immunotherapy
4.1.4 Cancer Vaccines
4.1.5 CAR-T Cell Therapy
4.1.6 Others
4.2 By Type - Italy Immuno-Oncology Revenue & Forecasts
4.2.1 By Type - Italy Immuno-Oncology Revenue, 2015-2020
4.2.2 By Type - Italy Immuno-Oncology Revenue, 2021-2026
4.2.3 By Type - Italy Immuno-Oncology Revenue Market Share, 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - Italy Immuno-Oncology Market Size, 2020 & 2026
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Italy Immuno-Oncology Revenue & Forecasts
5.2.1 By Application - Italy Immuno-Oncology Revenue, 2015-2020
5.2.2 By Application - Italy Immuno-Oncology Revenue, 2021-2026
5.2.3 By Application - Italy Immuno-Oncology Revenue Market Share, 2015-2026
6 Players Profiles
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporate Summary
6.1.2 Bristol-Myers Squibb Business Overview
6.1.3 Bristol-Myers Squibb Immuno-Oncology Major Product Offerings
6.1.4 Bristol-Myers Squibb Revenue in Italy (2015-2020)
6.1.5 Bristol-Myers Squibb Key News
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporate Summary
6.2.2 Merck & Co., Inc. Business Overview
6.2.3 Merck & Co., Inc. Immuno-Oncology Major Product Offerings
6.2.4 Merck & Co., Inc. Revenue in Italy (2015-2020)
6.2.5 Merck & Co., Inc. Key News
6.3 Roche AG
6.3.1 Roche AG Corporate Summary
6.3.2 Roche AG Business Overview
6.3.3 Roche AG Immuno-Oncology Major Product Offerings
6.3.4 Roche AG Revenue in Italy (2015-2020)
6.3.5 Roche AG Key News
6.4 AstraZeneca, Plc
6.4.1 AstraZeneca, Plc Corporate Summary
6.4.2 AstraZeneca, Plc Business Overview
6.4.3 AstraZeneca, Plc Immuno-Oncology Major Product Offerings
6.4.4 AstraZeneca, Plc Revenue in Italy (2015-2020)
6.4.5 AstraZeneca, Plc Key News
6.5 Sanofi S.A.
6.5.1 Sanofi S.A. Corporate Summary
6.5.2 Sanofi S.A. Business Overview
6.5.3 Sanofi S.A. Immuno-Oncology Major Product Offerings
6.5.4 Sanofi S.A. Revenue in Italy (2015-2020)
6.5.5 Sanofi S.A. Key News
6.6 Dendreon Pharmaceuticals
6.6.1 Dendreon Pharmaceuticals Corporate Summary
6.6.2 Dendreon Pharmaceuticals Business Overview
6.6.3 Dendreon Pharmaceuticals Immuno-Oncology Major Product Offerings
6.6.4 Dendreon Pharmaceuticals Revenue in Italy (2015-2020)
6.6.5 Dendreon Pharmaceuticals Key News
6.7 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Immuno-Oncology Major Product Offerings
6.4.4 Novartis Revenue in Italy (2015-2020)
6.7.5 Novartis Key News
6.8 Gilead Sciences Inc.
6.8.1 Gilead Sciences Inc. Corporate Summary
6.8.2 Gilead Sciences Inc. Business Overview
6.8.3 Gilead Sciences Inc. Immuno-Oncology Major Product Offerings
6.8.4 Gilead Sciences Inc. Revenue in Italy (2015-2020)
6.8.5 Gilead Sciences Inc. Key News
6.9 Merck KGaA
6.9.1 Merck KGaA Corporate Summary
6.9.2 Merck KGaA Business Overview
6.9.3 Merck KGaA Immuno-Oncology Major Product Offerings
6.9.4 Merck KGaA Revenue in Italy (2015-2020)
6.9.5 Merck KGaA Key News
7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for Italy Immuno-Oncology Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Key Players of Immuno-Oncology in Italy
Table 2. Top Players in Italy, Ranking by Revenue (2019)
Table 3. Italy Immuno-Oncology Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Italy Immuno-Oncology Revenue Share by Companies, 2015-2020
Table 5. Italy Immuno-Oncology Sales by Companies, (K Units), 2015-2020
Table 6. Italy Immuno-Oncology Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Immuno-Oncology Price (2015-2020) (US$/Unit)
Table 8. Italy Manufacturers Immuno-Oncology Product Type
Table 9. List of Italy Tier 1 Immuno-Oncology Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Italy Tier 2 and Tier 3 Immuno-Oncology Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Immuno-Oncology Revenue in Italy (US$, Mn), 2015-2020
Table 12. By Type - Immuno-Oncology Revenue in Italy (US$, Mn), 2021-2026
Table 13. By Type - Immuno-Oncology Sales in Italy (K Units), 2015-2020
Table 14. By Type - Immuno-Oncology Sales in Italy (K Units), 2021-2026
Table 15. By Application - Immuno-Oncology Revenue in Italy, (US$, Mn), 2015-2020
Table 16. By Application - Immuno-Oncology Revenue in Italy, (US$, Mn), 2021-2026
Table 17. By Application - Immuno-Oncology Sales in Italy, (K Units), 2015-2020
Table 18. By Application - Immuno-Oncology Sales in Italy, (K Units), 2021-2026
Table 19. Bristol-Myers Squibb Corporate Summary
Table 20. Bristol-Myers Squibb Immuno-Oncology Product Offerings
Table 21. Bristol-Myers Squibb Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 22. Merck & Co., Inc. Corporate Summary
Table 23. Merck & Co., Inc. Immuno-Oncology Product Offerings
Table 24. Merck & Co., Inc. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 25. Roche AG Corporate Summary
Table 26. Roche AG Immuno-Oncology Product Offerings
Table 27. Roche AG Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 28. AstraZeneca, Plc Corporate Summary
Table 29. AstraZeneca, Plc Immuno-Oncology Product Offerings
Table 30. AstraZeneca, Plc Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 31. Sanofi S.A. Corporate Summary
Table 32. Sanofi S.A. Immuno-Oncology Product Offerings
Table 33. Sanofi S.A. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 34. Dendreon Pharmaceuticals Corporate Summary
Table 35. Dendreon Pharmaceuticals Immuno-Oncology Product Offerings
Table 36. Dendreon Pharmaceuticals Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 37. Novartis Corporate Summary
Table 38. Novartis Immuno-Oncology Product Offerings
Table 39. Novartis Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 40. Gilead Sciences Inc. Corporate Summary
Table 41. Gilead Sciences Inc. Immuno-Oncology Product Offerings
Table 42. Gilead Sciences Inc. Immuno-Oncology Revenue (US$, Mn), (2015-2020)
Table 43. Merck KGaA Corporate Summary
Table 44. Merck KGaA Immuno-Oncology Product Offerings
Table 45. Merck KGaA Immuno-Oncology Revenue (US$, Mn), (2015-2020)
List of Figures
Figure 1. Immuno-Oncology Segment by Type
Figure 2. Immuno-Oncology Segment by Application
Figure 3. Italy Immuno-Oncology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Immuno-Oncology Market Size in Italy, (US$, Mn): 2020 VS 2026
Figure 6. Italy Immuno-Oncology Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-Oncology Revenue in 2019
Figure 8. By Type - Italy Immuno-Oncology Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - Italy Immuno-Oncology Market Share, 2015-2026
Figure 10. By Application - Immuno-Oncology Revenue in Italy (US$, Mn), 2020 & 2026
Figure 11. By Application - Italy Immuno-Oncology Market Share, 2015-2026
Figure 12. PEST Analysis for Italy Immuno-Oncology Market in 2020
Figure 13. Immuno-Oncology Market Opportunities & Trends in Italy
Figure 14. Immuno-Oncology Market Drivers in Italy
Global Cancer Immunomodulator Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period.
The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period.
The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 125
According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 112
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Cancer Gene Therapy market:
According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 85
CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.
The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
Global Kaposi Sarcoma Market Status and Outlook 2023-2028
Published: 22-Dec-2023 Price: US 3160 Onwards Pages: 107
Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 118
Market Overview of Global Cancer Immunomodulator market:
According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
